Post-transcriptional regulation of microRNAs in cancer: From prediction to validation

  • Sheril June Ankasha Department of Physiology, Faculty of Medicine, University Kebangsaan, Malaysia.
  • Mohamad Nasir Shafiee Department of Obstetrics and Gynaecology, Faculty of Medicine, University Kebangsaan, Malaysia.
  • Norhazlina Abdul Wahab Department of Physiology, Faculty of Medicine, University Kebangsaan, Malaysia.
  • Raja Affendi Raja Ali Gastroenterology Unit, Department of Medicine, Faculty of Medicine, University Kebangsaan, Malaysia.
  • Norfilza Mohd Mokhtar | Department of Physiology, Faculty of Medicine, University Kebangsaan, Malaysia.


MicroRNA (miRNA) is a small non-coding RNA with an established function to regulate genes at the post-transcriptional level leading to suppression or degradation of its messenger RNA expression (mRNA). Its dysregulation plays a vital role in a variety of biological and pathological processes including cancer. A lot of algorithms have been established to predict the target sites of miRNA, but experimentally identifying and validating its target region is still lacking. Guidance in experimental procedures is really needed to find genuine miRNA targets. Therefore, in this review, we provide an outline on the workflow in predicting and validating the targeted sites of miRNA using several methods as a guideline for the scientists. The final outcome of this type of experiment is essential to explore the major impact of miRNAmRNA interaction involved in the biological processes and to assist miRNA-based drug development in the future.


Download data is not yet available.


Lee RC. The C. elegans Heterochronic Gene lin-4 Encodes Small RNAs with Antisense Complementarity to &II-14. 1993;75:843–54.

Lujambio,; Lowe SW. The microcosmos of cancer Amaia. Nature. 2012;482(7385)(1):347–355.

Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell [Internet]. 2012;148(6):1172–87. Available from:

Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature [Internet]. 2011;469(7330):336–42. Available from:

Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol [Internet]. 2009;10(2):126–39. Available from:

Kozomara A, Griffiths-Jones S. MiRBase: Annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42(D1):68–73.

Dalmay T. Mechanism of miRNA-mediated repression of mRNA translation. Essays Biochem [Internet]. 2013;54:29–38. Available from:

Orang AV, Safaralizadeh R, Kazemzadeh-Bavili M. Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-specific upregulation. Int J Genomics. 2014;2014(June 2013).

Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci [Internet]. 2004;101(9):2999–3004. Available from:

Gennarino VA, D’Angelo G, Dharmalingam G, Fernandez S, Russolillo G, Sanges R, et al. Identification of microRNA-regulated gene networks by expression analysis of target genes. Genome Res. 2012;22(6):1163–72.

Bartel DP. MicroRNAs: Target Recognition and Regulatory Functions. Cell. 2009;136(2):215–33.

Cummins JM, Velculescu VE. Implications of micro-RNA profiling for cancer diagnosis. Oncogene [Internet]. 2006;25(46):6220–7. Available from:

Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 2009;24(4):652–7.

Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008;14(9):2690–5.

Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival Advances in Brief Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival. 2004;3753–6.

Michael MZ, O’ Connor SM, van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res. 2003;1(12):882–91.

Iorio M V., Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005;65(16):7065–70.

He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A [Internet]. 2005;102(52):19075–80. Available from:

Gebeshuber CA, Zatloukal K, Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep [Internet]. 2009;10(4):400–5. Available from:

Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci [Internet]. 2007;104(40):15805–10. Available from:

Majid S, Dar AA, Saini S, Deng G, Chang I, Greene K, et al. MicroRNA-23b Functions as a Tumor Suppressor by Regulating Zeb1 in Bladder Cancer. PLoS One. 2013;8(7).

Zaman MS, Thamminana S, Shahryari V, Chiyomaru T, Deng G, Saini S, et al. Inhibition of PTEN Gene Expression by Oncogenic miR-23b-3p in Renal Cancer. PLoS One. 2012;7(11).

Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov [Internet]. 2010;9(10):775–89. Available from:

Reddy KB. MicroRNA ( miRNA ) in cancer. Cancer Cell Int [Internet]. 2015;15:4–9. Available from: ???

Kosik KS, Krichevsky AM. The elegance of the microRNAs: A neuronal perspective. Neuron. 2005;47(6):779–82.

Liu C-G, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci [Internet]. 2004;101(26):9740–4. Available from:

Hammond SM. MicroRNAs as oncogenes. Curr Opin Genet Dev. 2006;16(1):4–9.

Satoh J, Tabunoki H. Comprehensive analysis of human microRNA target networks. BioData Min [Internet]. 2011;4(1):17. Available from:

Satoh J. Molecular network analysis of human microRNA targetome: from cancers to Alzheimer’s disease. Biodata Min. 2012;5:22.

Kloosterman WP, Wienholds E, Ketting RF, Plasterk RHA. Substrate requirements for let-7 function in the developing zebrafish embryo. Nucleic Acids Res. 2004;32(21):6284–91.

Lytle JR, Yario T a, Steitz J a. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5’ UTR as in the 3’ UTR. Proc Natl Acad Sci U S A. 2007;104(23):9667–72.

Kuhn DE, Martin MM, Feldman DS, Terry A V., Nuovo GJ, Elton TS. Experimental validation of miRNA targets. Methods. 2008;44(1):47–54.

Martin G, Schouest K, Kovvuru P, Spillane C. Prediction and validation of microRNA targets in animal genomes. J Biosci [Internet]. 2007;32(S2):1049–52. Available from:

Doench JG, Sharp PA. Specificity of microRNA target selection in translational repression. Genes Dev. 2004;18(5):504–11.

Seitz H. Redefining MicroRNA Targets. Curr Biol. 2009;19(10):870–3.

Min H, Yoon S. Got target?: computational methods for microRNA target prediction and their extension. Exp Mol Med [Internet]. 2010;42(4):233. Available from:

Saito T, Sætrom P. MicroRNAs - targeting and target prediction. N Biotechnol. 2010;27(3):243–9.

Bentwich I. Prediction and validation of microRNAs and their targets. FEBS Lett. 2005;579(26):5904–10.

Sethupathy P, Megraw M, Hatzigeorgiou AG. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods. 2006;3(11):881–6.

Easow G, Teleman AA, Cohen SM. Isolation of microRNA targets by miRNP immunopurification. Rna [Internet]. 2007;13(8):1198–204. Available from:

Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature [Internet]. 2008;455(7209):58–63. Available from:

Mestdagh P, Lefever S, Pattyn F, Ridzon D, Fredlund E, Fieuw A, et al. The microRNA body map: Dissecting microRNA function through integrative genomics. Nucleic Acids Res. 2011;39(20).

Angerstein C, Hecker M, Paap BK, Koczan D, Thamilarasan M, Thiesen HJ, et al. Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis. Mol Neurobiol. 2012;45(3):520–35.

Martinez-Sanchez A, Murphy C. MicroRNA Target Identification—Experimental Approaches. Biology (Basel) [Internet]. 2013;2(1):189–205. Available from:

Thomson DW, Bracken CP, Goodall GJ. Experimental strategies for microRNA target identification. Nucleic Acids Res. 2011;39(16):6845–53.

Hendrickson DG, Hogan DJ, McCullough HL, Myers JW, Herschlag D, Ferrell JE, et al. Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. PLoS Biol. 2009;7(11):25–9.

Kong YW, Cannell IG, de Moor CH, Hill K, Garside PG, Hamilton TL, et al. The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene. Proc Natl Acad Sci U S A [Internet]. 2008;105(26):8866–71. Available from:

Beitzinger M, Peters L, Zhu JY, Kremmer E, Meister G. Identification of Human microRNA Targets From Isolated Argonaute Protein Complexes. RNA Biol [Internet]. 2007;4(2):76–84. Available from:

Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P, et al. Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP. Cell [Internet]. 2010;141(1):129–41. Available from:

Karginov F V, Conaco C, Xuan Z, Schmidt BH, Parker JS, Mandel G, et al. A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci U S A [Internet]. 2007;104(49):19291–6. Available from:

Lee S-T, Chu K, Jung K-H, Kim JH, Huh J-Y, Yoon H, et al. miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model. Ann Neurol [Internet]. 2012;72(2):269–77. Available from:

Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, et al. MiR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer. 2010;127(12):2804–14.

microRNA, cancer, algorithm, target identification.
Abstract views: 782

PDF: 522
HTML: 67
Share it

PlumX Metrics

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

How to Cite
Ankasha, S., Shafiee, M., Wahab, N., Ali, R., & Mokhtar, N. (2018). Post-transcriptional regulation of microRNAs in cancer: From prediction to validation. Oncology Reviews, 12(1).